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Abstract

Background: Diabetes leads to numerous side effects, including an increased density of collagen fibrils and thickening of the Achilles tendon. This may increase tissue stiffness and could affect stretch distribution between muscle and tendinous tissues during walking. The primary aim of this study was to examine stretch distribution between muscle and tendinous tissues in the medial gastrocnemius muscle-tendon unit in long-term diabetes patients and control subjects during walking. 
Methods: Achilles tendon length changes were investigated in 13 non-neuropathic diabetes patients and 12 controls, whilst walking at a self selected speed across a 10m force platform. Electromyographic activity was recorded in the medial gastrocnemius, soleus and tibialis anterior muscles, goniometers were used to detect joint angle changes, and ultrasound was used to estimate tendon length changes. 
Findings: Achilles tendon length changes were attenuated in diabetes patients compared to controls, and were inversely correlated with diabetes duration (r = -0.628; P<0.05), as was ankle range of motion (r = -0.693; P<0.01). Tendon length changes were also independent of walking speed (r = -0.299; P = 0.224) and age (r = 0.115; P = 0.721) in the diabetic group.
Interpretation: Stretch distribution between muscle and tendon during walking is altered in diabetic patients, which could decrease walking efficiency, a factor that may be exacerbated with increasing diabetes duration. Diabetes-induced changes in mechanical tendon properties may be at least partly responsible for attenuated tendon length changes during walking in this patient group. 
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Introduction

Diabetes mellitus (DM) can lead to numerous side effects that have functional consequences for movement, such as deterioration in the function of large afferent nerve fibres (e.g. Muller et al., 2008), particularly the type Ia and II afferents originating in the muscle spindles (Nardone and Schieppati, 2007; Nielsen et al., 2004). As afferent receptors from muscle spindles are thought to contribute to the ongoing muscle activity during walking (e.g. af Klint et al., 2008; Sinkjaer et al., 2000), changes in their morphology due to diabetes could affect motor control during walking (e.g. Muller et al., 2008). Furthermore, as DM patients generally exhibit a decreased ability to rapidly produce force (Nielsen et al., 2004), the ability to recover from a balance disturbance during gait may be compromised, thus contributing to the increased fall risk reported in DM patients (e.g. Morley, 2007).

During walking, DM patients exhibit biomechanical deficits compared to age-matched healthy subjects. For example, slower walking speeds, shorter strides and greater co-contraction of agonist and antagonist muscles at the ankle and knee joints have all been reported in DM patients and patients with peripheral neuropathy, a nervous disorder often associated with DM (Kwon et al., 2003; Mueller et al., 1994). Although the kinematics and kinetics of diabetic gait are well documented, very little is known about the mechanical behaviour of muscle and tendinous tissues during gait in DM patients. Structural abnormalities have been observed in the Achilles tendon of DM patients, including an increased density of collagen fibrils, as well as thickening and vascularisation of the Achilles tendon (Giacomozzi et al., 2005; Grant et al., 1997; Ji et al., 2009). This may lead to increased tissue stiffness, and thus contribute to a loss of joint mobility. During the stance phase of human walking, muscle-tendon units (MTU) of the lower limb are naturally stretched (e.g. Ishikawa et al., 2005; Lichtwark and Wilson, 2006). This stretch is distributed between muscle and tendinous tissues depending on their relative stiffnesses (Rack and Westbury, 1984). Consequently, an increase in tendon stiffness may increase the stretch transferred to the muscle fibres during walking, which may in turn decrease movement efficiency by decreasing tendon elastic energy storage. As tendon disorganisation has been suggested to progressively increase with increasing diabetes duration (Batista et al., 2008), movement efficiency may also progressively decrease with increasing diabetes duration.

Based on the aforementioned neural and mechanical deficits observed in DM patients, one would expect tendon lengthening to be decreased during gait when compared to control subjects. This would change the pattern of stretch distribution within the MTU, and could have important functional consequences for muscle force production, afferent feedback and movement efficiency. The primary purpose of this study was to examine stretch distribution between muscle and tendinous tissues in the medial gastrocnemius (MG) MTU in long-term DM patients and control subjects during walking. An additional aim was to examine whether associations existed between diabetes duration and specific stretch, torque and gait parameters. It was hypothesised that DM patients would exhibit decreased rate of torque development and short latency stretch reflex (SLR) responses, as observed previously (Nielsen et al., 2004). During walking, it was anticipated that DM patients would exhibit attenuated tendon stretch responses compared to control subjects, and that this would be exacerbated as the duration of diabetes increased.

Methods

Subjects

To recruit DM patients, an advertisement was placed in a local publication. In total, 26 patients volunteered, 10 of whom did not meet the patient criteria. Three others withdrew from the measurements due to illness or injury, resulting in the collection of data from 13 patients (Table 1). Criteria for patient selection were: ability to comfortably walk 10 metres approximately 10 times with intermittent rest; diagnosis of DM; ability to walk independently without an assistive device; ability to lie supine; a minimum ankle range of motion of 40° (combined dorsi- and plantar flexion, which was determined prior to the measurements); unimpaired vision and hearing; and diabetes duration >10 years. Subjects were excluded if they had severe orthopedic abnormalities, severe neurological disorders, previous cerebrovascular accident, a history of plantar ulceration or previous lower extremity amputation. The mean duration of diabetes in the DM group was 31±12 years (range 15-54). Patients with a long duration of diabetes were recruited to ensure a high frequency of late diabetic complications. The level of neuropathy was assessed using the neuropathy disability score (NDS; Young et al., 1993) and neuropathy was defined as NDS > 5. All DM patients included in the study had an NDS score of ≤ 4. To recruit control subjects, an advertisement was placed in a local newspaper. In total, 32 subjects volunteered, and 12 were selected to enable age, height and body mass to be matched as closely as possible between groups (Table 1). Control subjects had no history of neuromuscular or skeletal disorders that could have influenced gait. A brief questionnaire was used to obtain medical and demographic data from all subjects. Patients and control subjects were all routinely active but did not regularly participate in sports. Prior to testing, the procedures were explained thoroughly, and all subjects provided written informed consent. All procedures conformed with the declaration of Helsinki, and the experiments were approved by the local ethics committees of the University of Jyväskylä and the Central Hospital of Central Finland, respectively. 

Study protocol

Prior to the measurements, resting Achilles tendon length was determined in the right leg of all subjects. For this procedure, subjects lay supine with a fully extended knee and an ankle angle of 90° (neutral position). The point at which the muscle and outer tendon converged was visually identified using ultrasound, and marked on the skin. The distance between this point and the distal insertion point (also confirmed by ultrasound) was defined as resting tendon length. 

In all testing conditions, electromyographic (EMG) activity was recorded in the MG, soleus (SOL) and tibialis anterior (TA) muscles of the right leg using bipolar surface electrodes (720, AMBU, Denmark) with a diameter of 5mm and an inter-electrode distance of 2 cm. Before electrode placement, the skin was shaved, abraded and cleaned with alcohol to maximise EMG signal quality. The electrodes were positioned as close to the respective muscle mid-belly as possible without interfering with the ultrasound probe position (see below). 

Stretch and maximum torque trials

In patients exhibiting signs of neurological impairment, stretch reflex amplitude and latency have been shown to be smaller and longer, respectively, compared to control subjects (Nielsen et al., 2004). To determine whether this was also the case for the present subject group, all of whom were classified as non-neuropathic, a series of rapid dorsiflexion stretches were performed. Subjects were seated in an ankle dynamometer, with the hip (120°), knee (180°) and ankle (90°) angles fixed (see Figure 1). Two straps were used to attach the foot to the dynamometer pedal, and the thigh was strapped to the seat to minimise leg movement. The upper body was also strapped to the upper part of the seat. Ten passive dorsiflexion stretches were induced (3°; 120°/s), with a minimum of 15s between consecutive trials. Throughout these trials, subjects completely relaxed the muscles of their right leg, and EMG activity was continuously monitored. Any trials showing deviation from the baseline EMG in any of the examined muscles prior to stretch were rejected. 

Maximal voluntary contractions (MVC) were performed with the ankle plantar- and dorsiflexors. In all trials, subjects were instructed to develop maximum torque as quickly as possible. At least three contractions were performed for each muscle group in a random order, with rest periods of 2-3 minutes between trials. Each trial required the maximal moment to be maintained for 2-3s. The trial exhibiting the highest peak moment value was selected as the MVC. Prior to all stretch and MVC trials, the ankle axis of rotation was carefully aligned with that of the ankle dynamometer. The order of the stretch and MVC trials was randomised.

Walking trials

During walking, an ultrasonographic device (Alpha-10; 7.5 MHz probes; Aloka, Japan) operating at 100 frames per second was used to measure the displacement of the MG muscle-tendon junction (MTJ), which was combined with the estimated displacement of the distal Achilles tendon to give an estimate of Achilles tendon length change. To position the probe accurately over the MTJ, the medial and lateral borders of the MG muscle were identified, and the midpoint between the two borders was marked on the skin. Sagittal-plane scans were then taken at the insertion point of the Achilles tendon, which was also marked on the skin. A straight line was drawn between the two points, and this line was assumed to be the operating axis of the muscle–tendon unit (MTU). The MTJ was identified as the intersection between the most distal part of the MG muscle and the outer tendon along the MTU operating axis. The probe was secured over the skin surface with a custom-made support device to minimise any probe movement relative to the skin. Echoabsorptive markers were also positioned between the probe and the skin within view of the ultrasound image to confirm that the probe did not move relative to the skin. The total additional weight due to the ultrasound probe was approximately 150g. The reliability of the ultrasound method of estimating MTJ displacement was determined by calculating the coefficient of variation between three different trials for each subject during walking. The mean value was 4±2%, which is similar to values reported previously during walking (Cronin et al., 2009a, 2009b). Goniometers (University of Jyväskylä, Finland) were attached to the lateral side of the ankle and knee joints in order to monitor joint angle changes during gait. Subjects were instructed to walk at a self selected speed across a 10m walkway, which was instrumented with two rows of force platforms capable of detecting ground reaction forces from both feet along the entire length of the walkway (Figure 2). All subjects wore low-heeled (less than 2.5 cm) shoes with a non-rockered sole. Each subject had several practice trials. Subsequently, joint angle, ground reaction force (GRF), EMG and ultrasound data were recorded from 8-12 trials per subject. A digital pulse was used to synchronise the kinetic, kinematic, EMG and ultrasound data. Subjects were allowed to rest as needed between trials. The order of the two broad test conditions (stretch/MVC and walking) was randomised, and all data were collected by the same two investigators. 

Data acquisition and analysis

For all conditions, EMG signals were amplified, band-pass filtered (10-1000 Hz), rectified and then low-pass filtered at 40 Hz. All EMG, goniometer and torque/GRF signals were sampled at 2 kHz and stored for later analysis. For the stretch trials, data from 10 trials were averaged for each subject, and SLR amplitude and latency were determined from the averaged EMG traces for each subject and for SOL and MG. To detect the onset latency of the SLR response, a window was defined from 20 to 60 ms after the stretch onset, which incorporates the physiological range for the onset of the SLR (e.g. Grey et al., 2004). Within this window, the onset of the SLR was determined as the moment at which the EMG signal exceeded 2 standard deviations of the mean pre-stimulus background EMG activity, averaged over 1 s. The amplitude of the SLR was then measured by subtracting mean pre-stimulus EMG from the peak EMG value within a 30 ms window starting at the SLR onset. As the medium latency component of the stretch reflex was not always clearly identifiable, this component was not analysed. Maximal torque in response to stretch was determined from the averaged torque trace. 

For the MVC trials, maximal torque was calculated from the stable portion of the torque curve over a 1s epoch from the trial exhibiting the highest torque value. In the same 1s epoch, the mean processed EMG amplitude was calculated, and used to normalise the EMG data obtained during walking (MG and SOL were normalised to plantar flexion MVC, and TA was normalised to dorsiflexion MVC). This method of normalization was chosen to provide a crude estimate of the degree of muscle activation required during gait (Burden et al., 2003), enabling a group comparison to be made for each muscle. Similarly, SLR amplitudes in MG and SOL were normalised to plantar flexion MVC.

For the walking trials, joint angle, GRF and EMG data were averaged for 50-60 steps per subject, and GRF and EMG signals were then normalised to body mass and MVC, respectively. For the ultrasound analysis, data from three trials were analysed and averaged. To select the trials to be analysed, the three trials where the ankle range of motion throughout the stance phase was closest to that of the mean ankle range of motion were selected, to ensure that these trials were representative of the mean response. In each ultrasound image, the MTJ was identified, and this point was tracked continuously throughout the stance phase. As this method only provides information about the movement of the proximal end of the tendon, Achilles tendon moment arms based on previous data during walking (Rugg et al., 1990) were combined with measured ankle joint angle changes to determine the rotation of the distal tendon, thus enabling the actual tendon length change to be estimated. Tendon length change was normalised to the length at the point of ground contact.

Statistics

Prior to analysis, data were tested for normality based on a Q-Q plot. To assess group differences, independent samples t-tests (normal distribution) or Mann-Whitney U tests (abnormal distribution) were used. To determine correlations between variables, Pearson’s (normal distribution) or Spearman’s (abnormal distribution) rank correlation coefficients were used. For all statistical tests, the level of significance was set at P < 0.05. Results are presented as means (SD).

Results

In 3 of the DM patients, it was not possible to elicit clear SLR responses in MG or SOL. As hypothesised, normalised SLR amplitudes were lower in DM patients compared to controls. Furthermore, in response to rapid stretches with no muscle pre-activation, as well as during MVC, DM patients showed a decreased rate of torque development. SLR and MVC data for both groups are shown in Table 2. 

In the walking trials, the inter-trial coefficient of variation for walking speed was 3.4% in the controls and 5.3% in the DM group. The controls walked significantly faster than the patients (1.27 (0.18) m/s vs. 1.06 (0.24) m/s; Independent t; P < 0.05), and exhibited a shorter mean stride duration (1.00 (0.10) s vs. 1.12 (0.12) s; Independent t; P < 0.05). Stance phase duration did not differ statistically between groups (722 (83) ms for controls vs. 800 (103) ms for patients; Independent t; P = 0.413), but the stance phase occupied a larger proportion of the total stride in the patients (63 (4) % vs. 60 (2) %; Independent t; P < 0.05). Between group differences in gait related parameters throughout the stance phase are shown in Figure 3. Peak tendon length change (relative to the length at ground contact) in the stance phase was not associated with walking speed in the controls (Pearson; r = -0.056, P = 0.862) or the patients (Pearson; r = -0.299, P = 0.224), nor was it associated with the range of ankle rotation during stance in either group (Spearman; r = -0.209, P = 0.537 and r = 0.305, P = 0.335 in controls and patients, respectively).

In the patient group, the duration of diabetes did not significantly correlate with normalised SLR amplitude (MG: Spearman; r = 0.257, P = 0.623; SOL: Pearson; r = 0.019, P = 0.923) or latency (MG: Spearman; r = -0.305, P = 0.248; SOL: Spearman; r = -0.396, P = 0.125). Similarly, no correlation was observed between diabetes duration and MVC or stretch-induced torque parameters (Pearson; r values between 0.171 and 0.410, P > 0.05). During walking, diabetes duration was inversely correlated with peak tendon length change (Pearson; r = -0.628, P < 0.05), showing that increased diabetes duration was associated with greater decrements in tendon lengthening (Figure 4). Diabetes duration was negatively correlated with the range of ankle joint rotation during stance (Pearson; r = -0.693, P < 0.01), but was not correlated with the range of knee joint rotation (Pearson; r = -0.083, P = 0.798). Neither the duration of diabetes (Pearson; r = -0.117, P = 0.703) nor the range of ankle joint rotation (Pearson; r = 0.272, P = 0.369) correlated with walking speed. Diabetes duration was also unrelated to age (Pearson; r = 0.115, P = 0.721).

Discussion

The main findings of this study were that Achilles tendon length changes during walking were attenuated in long-term diabetic patients compared to control subjects. Although DM patients walked slower than control subjects, no differences were observed in mean ankle or knee trajectories during the stance phase. As there were no differences between groups in shank length (41 (4) versus 40 (3) cm) or resting tendon length (18.4 (3) versus 19 (3) cm), the data suggest that MTU length changes during stance were similar between groups. Therefore, the smaller tendon length changes observed in the DM group may be at least partly attributable to changes in tendon properties, as previously reported (Giacomozzi et al., 2005). Peak tendon lengthening also decreased with increasing diabetes duration. Therefore, changes in tissue properties due to diabetes may be progressive (Batista et al., 2008), even in the absence of peripheral neuropathy. Similar MTU length changes but smaller tendon length changes imply a greater stretch of the muscle fascicles and aponeurosis in the DM group. These changes in stretch distribution could decrease elastic energy storage in the tendon, and increase the amount of work performed by the muscle fibres, which would decrease walking efficiency in this population (e.g. Sawicki et al., 2009). The hypothesis that the muscle fibres are required to perform more work may be supported by the finding that relative muscle activation was higher in TA and similar in MG and SOL in the DM group compared to controls. As the patients walked slower, they actually required greater relative activation of all muscles to achieve a given walking speed.

Within the DM group, ankle joint rotation during the stance phase decreased as diabetes duration increased. This finding may support the hypothesis that changes in structural tissue properties related to DM contribute to decreased joint mobility (Delbridge et al., 1985, 1988; Hajrasouliha et al., 2005). However, as no differences were observed in mean ankle or knee trajectories between groups, it seems that joint mobility may only be compromised in very long term diabetes patients. Nonetheless, these data clearly show that increased diabetes duration is associated with decreased tendon lengthening during walking. Previous studies have shown that in healthy individuals, the Achilles tendon is stretched during stance, storing elastic energy, and then rapidly recoils (and returns elastic energy) during pushoff, and this helps humans to move efficiently (e.g. Alexander and Bennet-Clark, 1977; Ishikawa et al., 2005). Data from the present study suggest that in DM patients, this mechanism is less effective, particularly in the terminal stance phase (70-100%), where ankle strength and mobility have their greatest effect (Mueller et al., 1994).  

In the present study, DM patients showed lower SLR amplitudes and a lower amplitude and slope of the torque response to stretch in the plantar- and dorsiflexors. Maximal voluntary torque amplitude did not differ between the groups, but the slope of the torque response was lower in the patients. Similar observations have been reported previously after electrically evoked contractions of the soleus muscle (Nielsen et al., 2004). The latter study also reported longer SLR latencies in the SOL muscle of DM patients, which was not observed here, although there was a trend towards longer latencies in MG and SOL. As DM patients generally walk slower than control subjects, a decreased ability to produce force quickly may not be a major limitation during normal undisturbed gait. However, in response to balance disturbances during gait, an increase in the time taken for force production in the plantar- and dorsiflexors could induce a delay in the mechanical response, which in combination with decreased function of large afferents, could decrease the ability to compensate for balance disturbances (e.g. Dingwell et al., 1999; Gutierrez et al., 2001), particularly as large afferents are thought to contribute to recovery from such disturbances (e.g. Sinkjaer et al., 2000). These factors are likely to contribute to increased fall risk in DM patients. No clear relationships were observed between diabetes duration and stretch or torque responses, suggesting that changes in these parameters may be independent of diabetes duration. However, the possibility cannot be excluded that the relatively small sample size in this study prevented a clear relationship from emerging. 

Based on the methodology employed, the muscle-tendon junction was assumed to only shift in the scanning plane. Medio-lateral and/or antero-posterior displacement would thus result in minor measurement errors. Moment arm lengths were also estimated based on previous data obtained from younger subjects (Rugg et al., 1990), which could introduce some errors in tendon length estimation. Since Achilles tendon moment arms do not differ between young and elderly subjects (Morse et al., 2005), this error is likely to have been minimal. Nonetheless, as changes in muscle thickness during contraction can affect moment arm lengths (Maganaris et al., 1998), and muscle thickness was not measured in this study, the possibility cannot be excluded that this parameter influenced our data. It should also be noted that tendon length was not directly measured. Although direct methods have been used to study muscle-tendon interaction in animals (e.g. Daley et al., 2009), this method is highly invasive and has not been successfully applied in humans. Similarly, structural properties of the Achilles tendon were not measured in this study. However, tendon disorganisation has been reported to be present in diabetic individuals and absent in age-matched controls (Batista et al., 2008). The fact that the right leg was measured for all subjects may be a limitation, as leg dominance differed between subjects. Due to the cable attached to the ultrasound probe, which could have inhibited natural walking if attached to the left leg, this was unavoidable. It could also be argued that it is difficult to compare groups walking at different speeds. However, since DM patients naturally walk slower than controls, any efforts to match walking speeds would require one subject group to walk at an unnatural speed, which could alter various parameters including balance, patterns of muscle activation and muscle-tendon length changes (see Cronin et al., 2009b). Such changes would render a comparison between groups inappropriate. Furthermore, knee and ankle joint kinematics were similar between groups, as were shank lengths, suggesting that MTU length changes were also similar. As one aim of this study was to examine MTU stretch distribution, these findings validate the use of unmatched walking speeds in this study. Finally, the small sample size in this study is also a limitation, albeit unavoidable due to the specificity of the inclusion criteria.

Conclusions

In the human lower limb, Achilles tendon length changes during walking are attenuated in long-term diabetic patients compared to control subjects. This difference cannot solely be attributed to differences in walking speed or joint kinematics between the groups, and appears to be exacerbated by increased diabetes duration. These changes are likely to decrease the capacity of the tendon to store elastic energy, and result in a larger stretch of the muscle fascicles and/or aponeurosis. Movement efficiency may thus be compromised in this population, and this may worsen as the duration of diabetes increases. As DM patients also exhibited a decreased ability to rapidly produce force, and impaired short latency stretch reflexes, the ability to overcome unexpected balance disturbances during gait may be compromised in DM patients, even in the absence of peripheral neuropathy. 
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Figure legends

Figure 1. Experimental setup for the stretch and MVC trials. A: Schematic of the subjects’ joint configurations whilst sitting in the ankle dynamometer. B: A fully instrumented subject seated in the ankle dynamometer.

Figure 2. Experimental setup for the walking trials. A: One subject from the DM group. The ultrasound device was placed on a carriage and pushed alongside the subject while they walked along the force platform. B: Schematic of the equipment used during the walking trials.

Figure 3. Changes in gait parameters throughout the entire stance phase. A: GRF normalised to body mass (Vertical force: thin traces; Antero-posterior force: thick traces); B: Ankle trajectory; C: Knee trajectory; D: MG EMG; E: TA EMG; F: Achilles tendon length relative to length at ground contact. In all cases, data were averaged from 13 patients and 12 controls. * and ** denote a significant difference between groups across the entire stance phase at P < 0.05 and P < 0.01, respectively. Soleus EMG is not shown since no differences were observed in relative activation between groups in this muscle.

Figure 4. Correlations between diabetes duration and specific gait parameters. A: Peak Achilles tendon lengthening throughout the entire stance phase. B: Mean walking speed. C: Range of ankle joint rotation during the stance phase. In all cases, n = 13.
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